In Depth

Inborn errors of metabolism elicit unique challenges for therapy development

GLP-1RAs and opioid use disorder: a new frontier in addiction treatment

European agencies catch up with speedier regulatory pathways for CGTs in the US

USAID funding fallout: sponsors, and agencies may have to fill funding gap

Pfizer’s bet on gene therapies in haemophilia has been a bust